[go: up one dir, main page]

NO942228L - Ipsapiron-legemiddeltilberedning - Google Patents

Ipsapiron-legemiddeltilberedning

Info

Publication number
NO942228L
NO942228L NO942228A NO942228A NO942228L NO 942228 L NO942228 L NO 942228L NO 942228 A NO942228 A NO 942228A NO 942228 A NO942228 A NO 942228A NO 942228 L NO942228 L NO 942228L
Authority
NO
Norway
Prior art keywords
hours
release
ipsapirone
drug preparation
ipsaplron
Prior art date
Application number
NO942228A
Other languages
English (en)
Norwegian (no)
Other versions
NO942228D0 (no
Inventor
Peter Serno
Wolfgang Fischer
Roland Rupp
Mark Versavel
Ulrich Tenter
Gerhard Schmidt
Gunter Schollnhammer
Maria Ammen
Shinji Maegata
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO942228D0 publication Critical patent/NO942228D0/no
Publication of NO942228L publication Critical patent/NO942228L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO942228A 1993-06-15 1994-06-14 Ipsapiron-legemiddeltilberedning NO942228L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4319760A DE4319760A1 (de) 1993-06-15 1993-06-15 Ipsapiron Arzneimittelzubereitung

Publications (2)

Publication Number Publication Date
NO942228D0 NO942228D0 (no) 1994-06-14
NO942228L true NO942228L (no) 1994-12-16

Family

ID=6490360

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942228A NO942228L (no) 1993-06-15 1994-06-14 Ipsapiron-legemiddeltilberedning

Country Status (16)

Country Link
EP (1) EP0629402A1 (sv)
JP (1) JPH06345649A (sv)
KR (1) KR950000150A (sv)
CN (1) CN1099263A (sv)
AU (1) AU6345794A (sv)
CA (1) CA2125620A1 (sv)
CZ (1) CZ146494A3 (sv)
DE (1) DE4319760A1 (sv)
FI (1) FI942803A7 (sv)
HU (1) HUT70759A (sv)
IL (1) IL109993A0 (sv)
NO (1) NO942228L (sv)
NZ (1) NZ260732A (sv)
PL (1) PL303822A1 (sv)
SK (1) SK72494A3 (sv)
ZA (1) ZA944187B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
EP1140105B1 (en) * 1998-12-24 2003-10-22 Janssen Pharmaceutica N.V. Controlled release galantamine composition
WO2004103338A1 (en) * 2003-05-19 2004-12-02 Bioprogress Plc Adhesives and film modifying compositions
EP4062913B1 (en) * 2020-09-02 2024-05-08 Beijing Biostar Pharmaceuticals Co., Ltd. Solid oral formulation of utidelone

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0386440T3 (da) * 1989-02-11 1992-09-14 Bayer Ag Lægemidler med kontrolleret afgivelse af virksomt stof
DD297767A5 (de) * 1990-03-06 1992-01-23 Bayer Aktiengesellschaft,De Arzneimittel mit kontrollierter wirkstoffabgabe
JPH04360826A (ja) * 1991-06-07 1992-12-14 Bayer Yakuhin Kk 放出制御製剤

Also Published As

Publication number Publication date
CN1099263A (zh) 1995-03-01
NZ260732A (en) 1996-02-27
KR950000150A (ko) 1995-01-03
IL109993A0 (en) 1994-10-07
FI942803L (sv) 1994-12-16
DE4319760A1 (de) 1994-12-22
ZA944187B (en) 1995-02-08
NO942228D0 (no) 1994-06-14
JPH06345649A (ja) 1994-12-20
FI942803A0 (sv) 1994-06-13
CZ146494A3 (en) 1995-01-18
EP0629402A1 (de) 1994-12-21
FI942803A7 (sv) 1994-12-16
SK72494A3 (en) 1995-04-12
PL303822A1 (en) 1995-01-09
HU9401771D0 (en) 1994-09-28
CA2125620A1 (en) 1994-12-16
HUT70759A (en) 1995-10-30
AU6345794A (en) 1994-12-22

Similar Documents

Publication Publication Date Title
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
CA2327973A1 (en) Storage system for powdered pharmaceuticals, and inhaler equipped with this system
AU6995794A (en) Aspb28 insulin crystals
TR199802034T2 (xx) �apraz ba�lant�l� amylose ve hydroxypropylmethylcellulose baz�nda bir ta��y�c� i�eren kontroll� ��z�l�ml� farmas�tik tablet.
GEP20012442B (en) Irreversible Inhibitors of Tyrosine Kinases
IT8719064A0 (it) Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive.
DK1171573T3 (da) ARPE-19, som en platform-cellelinie for indkapslet cellebaseret indgivelse
NO953278D0 (no) Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette
AU692430C (en) Aqueous pharmaceutical preparations of G-CSF with a long shelf life
WO1994012165A3 (en) Enzyme inhibitors
UA66417C2 (en) Recombinant adenovirus affecting canines, pharmaceutical composition
EP1452172A3 (en) Multiple unit pharmaceutical preparation
CA2264901A1 (fr) Association inhibiteurs de no synthase et piegeurs des formes reactives de l'oxygene
CA2030838A1 (en) Preparations containing l-carnitine
ATE397665T1 (de) Lymphotoxin-beta, lymphotoxin-beta komplexe, pharmazeutische zubereitungen und therapeutische verwendungen davon
EP0147146A3 (en) Enhancement of transdermal drug delivery
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
CO5011082A1 (es) Formulacion medicamentosa con liberacion controlada de sus- tancia activa
TW327602B (en) A pharmaceutical composition of an ophthalmic suspension containing difluprednate
EP0514464A4 (en) Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
NO942228L (no) Ipsapiron-legemiddeltilberedning
AU687623B2 (en) Cell Adhesion peptides for use in modifying mutual adhesion among eukaryotic cells
NO994898D0 (no) Cytomodulering av lipofile peptider for aa modulere immunsystemaktivitet og inhibere inflammasjon
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system